# Molar Potency Study of HM12460A in Healthy Subjects

> **NCT03330314** · PHASE1 · COMPLETED · sponsor: **Hanmi Pharmaceutical Company Limited** · enrollment: 38 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **BIOLOGICAL:** HM12460A

## Key facts

- **NCT ID:** NCT03330314
- **Lead sponsor:** Hanmi Pharmaceutical Company Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-10-24
- **Primary completion:** 2018-02-08
- **Final completion:** 2018-02-08
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2020-08-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03330314

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03330314, "Molar Potency Study of HM12460A in Healthy Subjects". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03330314. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*